
Deficiency, alpha-1 antitrypsin: An inherited disorder characterized by a lack of the alpha-1 antitrypsin protease inhibitor. <a href="https://www.medicinenet.com/alpha_1_antitrypsin_deficiency/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">Alpha-1 antitrypsin deficiency</a> leads to damage of various organs, especially the lung and liver. Symptoms may become apparent at a very early age or anytime later, manifesting as shortness of breath due to <a href="https://www.medicinenet.com/emphysema_lung_condition/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">emphysema</a> or as liver symptoms such as <a href="https://www.medicinenet.com/jaundice_in_adults/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">jaundice</a>, <a href="https://www.medicinenet.com/fatigue/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">fatigue</a>, fluid in the abdomen, mental changes, or gastrointestinal bleeding. Treatment options include, for lung disease, replacement of the missing alpha-1 antitrypsin. Avoidance of <a href="https://www.medicinenet.com/smoking_and_quitting_smoking/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">smoking</a> and of other lung irritants is an important part of management. Treatment of the <a href="https://www.medicinenet.com/liver_disease/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">liver disease</a> is <a href="https://www.medicinenet.com/liver_transplant/article.htm" onclick="wmdTrack('embd-lnk');" rel="proc">liver transplant</a>. Also known as protease inhibitor 1 deficiency.